Organism name | Lindera glauca |
---|---|
Genus | Lindera |
Family | Lauraceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Lindera glauca |
---|---|
Linked NCBI taxonomy ID | 332435 |
Linked level | species |
Family in NCBI taxonomy | Lauraceae |
---|---|
ID | 3433 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | Magnoliophyta |
---|---|
ID | 3398 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00027438
![]() |
Sanjoinine Ib
/ Norisocorydine |
CHEMBL465212
|
No. 20 | No. 4 |
![]() |
|||
C00027304
![]() |
Boldine
/ d-Boldine / (+)-Boldine |
CHEMBL388342
CHEMBL1321247 CHEMBL1437753 |
C011686
|
34 / 32 / 35 | No. 20 | No. 4 |
![]() |
|
C00001869
![]() |
Isoboldine
/ (S)-Isoboldine |
CHEMBL462880
|
19 / 22 / 55 | No. 20 | No. 4 |
![]() |
||
C00025675
![]() |
Lauroscholtzine
/ 2-O-Methylboldine / N-Methyllaurotetanine / (+)-N-Methyllaurotetanine |
CHEMBL464099
|
1 / 1 / 0 | No. 20 | No. 4 |
![]() |
||
C00027405
![]() |
Laetanine
/ (+)-Laetanine |
No. 20 | No. 4 |
![]() |
||||
C00027433
![]() |
Laurolitsine
/ (+)-Norboldine / (+)-Laurolitsine |
CHEMBL487388
|
C109133
|
No. 20 | No. 4 |
![]() |
||
C00001827
![]() |
Canadine
/ Xanthopuccine / Tetrahydroberberine / Tetrahydroumbellatine |
CHEMBL275097
CHEMBL490533 CHEMBL476501 |
C004645
|
22 / 36 / 28 | No. 37 | No. 4 |
![]() |
|
C00025935
![]() |
Lysicamine
/ Oxonuciferine |
CHEMBL510090
|
C069090
|
No. 74 |
![]() |
|||
C00026002
![]() |
Pallidine
/ (-)-Pallidine / (-)-Isosalutaridine |
No. 426 | No. 4 |
![]() |
||||
C00027426
![]() |
N-Methylflavinantine
|
No. 426 | No. 4 |
![]() |
||||
C00025334
![]() |
trans-Feruloyltyramine
/ N-trans-Feruloyltyramine / trans-N-Feruloyltyramine |
CHEMBL206555
CHEMBL451720 |
1 / 4 / 2 | No. 499 |
![]() |
|||
C00025324
![]() |
N-cis-Feruloyltyramine
/ cis-N-Feruloyltyramine |
CHEMBL206555
CHEMBL451720 |
1 / 4 / 2 | No. 499 |
![]() |
|||
C00000661
![]() |
N-trans-Sinapoyltyramine
|
CHEMBL226587
|
No. 499 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001827 C00001869 C00027304 | 1 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001827 C00001869 C00027304 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001827 C00001869 C00027304 | 0 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001827 C00001869 C00027304 | 0 / 1 |
O00255 | Menin | Unclassified protein | C00001827 C00001869 C00027304 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001827 C00001869 C00027304 | 1 / 2 |
P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00001827 C00025675 | 1 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00001869 C00027304 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00001827 C00027304 | 11 / 10 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00001869 C00027304 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00001827 C00027304 | 1 / 1 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00001869 C00027304 | 0 / 1 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00001869 C00027304 | 4 / 3 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001869 C00027304 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00001827 C00027304 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00001869 C00027304 | 0 / 0 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00001869 C00027304 | 1 / 4 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00001869 C00027304 | 2 / 2 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00001869 C00027304 | 3 / 3 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001827 C00027304 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00001827 C00027304 | 0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00025324 C00025334 | 4 / 2 |
P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00027304 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00027304 | 1 / 1 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00027304 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00001827 | 7 / 3 |
P13726 | Tissue factor | Membrane receptor | C00001827 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00001827 | 2 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00027304 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00027304 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00027304 | 0 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001827 | 0 / 0 |
P55210 | Caspase-7 | C14 | C00001869 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00027304 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00001827 | 2 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00027304 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001827 | 0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00027304 | 1 / 0 |
P43681 | Neuronal acetylcholine receptor subunit alpha-4 | CHRN alpha | C00027304 | 1 / 1 |
P17787 | Neuronal acetylcholine receptor subunit beta-2 | CHRN beta | C00027304 | 1 / 1 |
P24941 | Cyclin-dependent kinase 2 | Cdc2 | C00001827 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00027304 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00001869 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00027304 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00001869 | 0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00027304 | 1 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001827 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00001869 | 7 / 37 |
Q14654 | ATP-sensitive inward rectifier potassium channel 11 | K | C00001827 | 3 / 4 |
Q09428 | ATP-binding cassette sub-family C member 8 | K | C00001827 | 5 / 3 |
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P14416
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#606176 | Diabetes mellitus, permanent neonatal; pndm |
Q09428
Q14654 |
#610374 | Diabetes mellitus, transient neonatal, 2 |
Q09428
|
#610582 | Diabetes mellitus, transient neonatal, 3 |
Q14654
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#600513 | Epilepsy, nocturnal frontal lobe, 1; enfl1 |
P43681
|
#605375 | Epilepsy, nocturnal frontal lobe, 3; enfl3 |
P17787
|
#133239 | Esophageal cancer |
P04637
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#232300 | Glycogen storage disease ii |
P10253
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#256450 | Hyperinsulinemic hypoglycemia, familial, 1; hhf1 |
Q09428
|
#601820 | Hyperinsulinemic hypoglycemia, familial, 2; hhf2 |
Q14654
|
#602485 | Hyperinsulinemic hypoglycemia, familial, 3; hhf3 |
Q09428
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#240800 | Hypoglycemia, leucine-induced; lih |
Q09428
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#211980 | Lung cancer |
P04637
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#159900 | Myoclonic dystonia |
P14416
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
|
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00807 | Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) |
P17787
(related)
P43681 (related) |
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00512 | Permanent neonatal diabetes mellitus (PNDM) |
Q09428
(related)
Q14654 (related) |
H00513 | Transient neonatal diabetes mellitus (TNDM) |
Q09428
(related)
Q14654 (related) |
H01267 | Familial hyperinsulinemic hypoglycemia (HHF) |
Q09428
(related)
Q14654 (related) |
H00409 | Type II diabetes mellitus |
Q14654
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|